NZ503044A - Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors - Google Patents
Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitorsInfo
- Publication number
- NZ503044A NZ503044A NZ503044A NZ50304498A NZ503044A NZ 503044 A NZ503044 A NZ 503044A NZ 503044 A NZ503044 A NZ 503044A NZ 50304498 A NZ50304498 A NZ 50304498A NZ 503044 A NZ503044 A NZ 503044A
- Authority
- NZ
- New Zealand
- Prior art keywords
- alkyl
- aryl
- hydrogen
- compound
- aryialkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93711997A | 1997-09-24 | 1997-09-24 | |
| US99015097A | 1997-12-12 | 1997-12-12 | |
| US10411498A | 1998-06-25 | 1998-06-25 | |
| PCT/FI1998/000755 WO1999015523A1 (fr) | 1997-09-24 | 1998-09-24 | Bisethers de 1-oxa, aza et thianaphtalene-2-one inhibiteurs du phospholambane |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ503044A true NZ503044A (en) | 2001-08-31 |
Family
ID=27379660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ503044A NZ503044A (en) | 1997-09-24 | 1998-09-24 | Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1017691A1 (fr) |
| JP (1) | JP2003525838A (fr) |
| KR (1) | KR20010015607A (fr) |
| CN (1) | CN1143857C (fr) |
| AU (1) | AU735729B2 (fr) |
| BR (1) | BR9813216A (fr) |
| CA (1) | CA2304849A1 (fr) |
| EA (1) | EA003084B1 (fr) |
| EE (1) | EE04494B1 (fr) |
| HU (1) | HUP0003647A3 (fr) |
| ID (1) | ID24373A (fr) |
| IL (1) | IL134662A0 (fr) |
| NO (1) | NO20001569L (fr) |
| NZ (1) | NZ503044A (fr) |
| PL (1) | PL339493A1 (fr) |
| SK (1) | SK3902000A3 (fr) |
| TR (1) | TR200000764T2 (fr) |
| WO (1) | WO1999015523A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7026491B2 (en) | 2000-07-21 | 2006-04-11 | Chugai Seiyaku Kabushiki Kaisha | Coumarin derivatives useful as TNFα inhibitors |
| AU2002226634B2 (en) * | 2001-03-30 | 2007-01-25 | Pfizer Products Inc. | Pyridazinone aldose reductase inhibitors |
| US7572910B2 (en) | 2003-02-20 | 2009-08-11 | Pfizer, Inc. | Pyridazinone aldose reductase inhibitors |
| FR2970964B1 (fr) * | 2011-01-28 | 2013-12-13 | Univ Claude Bernard Lyon | Nouveaux derives d'azacoumarines presentant une activite inhibitrice des pompes mdr |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2543945A1 (de) * | 1975-10-02 | 1977-04-21 | Troponwerke Gmbh & Co Kg | 2-benzopyranonderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| GB8529362D0 (en) * | 1985-11-28 | 1986-01-02 | Pfizer Ltd | Quinolone cardiac stimulants |
| GB8630702D0 (en) * | 1986-12-23 | 1987-02-04 | Wellcome Found | Quinoline compound |
| DK391189A (da) * | 1988-08-10 | 1990-02-11 | Otsuka Pharma Co Ltd | Carbostyrilderivater |
| CA2022236A1 (fr) * | 1989-07-31 | 1991-02-01 | Hiroaki Yanagisawa | Derives de coumarin, leur preparation et leur utilisation pour le traitement des troubles cerebrovasculaires |
| DE4337906A1 (de) * | 1993-11-08 | 1995-05-11 | Cassella Ag | Verwendung von Cumarinderivaten |
-
1998
- 1998-09-24 ID IDW20000564A patent/ID24373A/id unknown
- 1998-09-24 AU AU93508/98A patent/AU735729B2/en not_active Ceased
- 1998-09-24 CA CA002304849A patent/CA2304849A1/fr not_active Abandoned
- 1998-09-24 TR TR2000/00764T patent/TR200000764T2/xx unknown
- 1998-09-24 KR KR1020007003094A patent/KR20010015607A/ko not_active Application Discontinuation
- 1998-09-24 PL PL98339493A patent/PL339493A1/xx unknown
- 1998-09-24 EE EEP200000179A patent/EE04494B1/xx not_active IP Right Cessation
- 1998-09-24 EA EA200000352A patent/EA003084B1/ru not_active IP Right Cessation
- 1998-09-24 NZ NZ503044A patent/NZ503044A/en unknown
- 1998-09-24 HU HU0003647A patent/HUP0003647A3/hu unknown
- 1998-09-24 EP EP98946482A patent/EP1017691A1/fr not_active Withdrawn
- 1998-09-24 JP JP2000512828A patent/JP2003525838A/ja active Pending
- 1998-09-24 CN CNB98809438XA patent/CN1143857C/zh not_active Expired - Fee Related
- 1998-09-24 SK SK390-2000A patent/SK3902000A3/sk unknown
- 1998-09-24 IL IL13466298A patent/IL134662A0/xx unknown
- 1998-09-24 BR BR9813216-4A patent/BR9813216A/pt not_active IP Right Cessation
- 1998-09-24 WO PCT/FI1998/000755 patent/WO1999015523A1/fr not_active Application Discontinuation
-
2000
- 2000-03-24 NO NO20001569A patent/NO20001569L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9813216A (pt) | 2000-08-29 |
| AU9350898A (en) | 1999-04-12 |
| EE04494B1 (et) | 2005-06-15 |
| CN1271357A (zh) | 2000-10-25 |
| EE200000179A (et) | 2001-04-16 |
| PL339493A1 (en) | 2000-12-18 |
| HUP0003647A2 (hu) | 2001-08-28 |
| ID24373A (id) | 2000-07-13 |
| CN1143857C (zh) | 2004-03-31 |
| EA003084B1 (ru) | 2002-12-26 |
| TR200000764T2 (tr) | 2001-03-21 |
| HUP0003647A3 (en) | 2002-12-28 |
| IL134662A0 (en) | 2001-04-30 |
| AU735729B2 (en) | 2001-07-12 |
| JP2003525838A (ja) | 2003-09-02 |
| NO20001569D0 (no) | 2000-03-24 |
| NO20001569L (no) | 2000-03-24 |
| KR20010015607A (ko) | 2001-02-26 |
| EP1017691A1 (fr) | 2000-07-12 |
| CA2304849A1 (fr) | 1999-04-01 |
| SK3902000A3 (en) | 2000-12-11 |
| WO1999015523A1 (fr) | 1999-04-01 |
| EA200000352A1 (ru) | 2000-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7113009B2 (ja) | 置換ピリジノン含有三環式化合物およびそれを使用する方法 | |
| US4725691A (en) | 2-[8-quinolinyl]-sulphinyl-1H-benzimidazole | |
| KR102137517B1 (ko) | 신규 5-아미노테트라히드로퀴놀린-2-카르복실산 및 그의 용도 | |
| JP6324956B2 (ja) | 置換アミノインダン−およびアミノテトラリンカルボン酸ならびにその使用 | |
| EP1039884B1 (fr) | Methode de prevention et de traitement de la sideration myocardique | |
| BR112021014079A2 (pt) | Ácidos carboxílicos policíclicos substituídos, análogos dos mesmos e métodos usando os mesmos | |
| WO2004050082A1 (fr) | Nouveaux derives coumarine-amide et leur preparation, composition medicamenteuse associee et son utilisation | |
| KR20080091948A (ko) | 락탐형 피리딘 화합물을 포함하는 허혈성 질환의 예방 및치료용 약학조성물 | |
| JPS6360936A (ja) | 複合薬剤 | |
| US4707479A (en) | Circulation active dihydropyridine-3-carboxamides | |
| US6265421B1 (en) | Phospholamban inhibitors and a method for increasing coronary flow | |
| BG60403B2 (bg) | Оксадиазолови алкил-пуринови производни,полезни като агенти против кашлица | |
| US4910206A (en) | 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists | |
| NZ503044A (en) | Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors | |
| EP1001774B1 (fr) | Utilisation d'inhibiteurs de phospholamban pour augmenter le debit coronaire | |
| BG65859B1 (bg) | Пиридазинил фенил хидразони, полезни срещу конгестивна сърдечна недостатъчност | |
| MXPA00002954A (en) | Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors | |
| CA1059511A (fr) | Acide 4-oxo-4h-pyrano-(3,2,-c)-quinoline-2-carboxyliques et leurs sels | |
| CZ2000937A3 (cs) | Bisethery 1-oxa, aza a thianaftalen-2-onu jako inhibitory fosfolambanu a farmaceutické prostředky | |
| EP1450812A2 (fr) | Utilisation de benzopyranones pour le traitement ou la prevention d'un cancer primitif du cerveau ou d'une metastase cerebrale | |
| JP2000509726A (ja) | 糖尿病処置用のオキシランカルボン酸 | |
| KR20080091949A (ko) | 락톤형 피리딘 화합물을 포함하는 허혈성 질환의 예방 및치료용 약학조성물 | |
| HUT70483A (en) | Quinolyl-dihydropyridin-esters, process for producing them and their use for preparing pharmaceutical compositions | |
| EP1280783A2 (fr) | Methodes de traitement mettant en oeuvre des benzoxazinones comme modulateurs du recepteur gamma active par le proliferateur du peroxisome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |